SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$TGTX Options Flow š¤ analysis suggests a bullish ... See more
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ... See more
NKLA
Nikola Corporation
-37.93%
$2.61 - $1.62
Feb 7th 2023 - Mar 21st 2023
Feb, 28, 2023
Their advanced algorithms and expert analysis prov... See more
Nov, 30, 2022
Full Technical Analysis at https://youtu.be/2qmFW5... See more
Nov, 7, 2022
$SAVA Lost in all the analysis are some simple facts; The drug is safe.
Mar, 21, 2023
$TGTX Options Flow š¤ analysis suggests a bullish outlook for the stock.
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ublituximab was associated with significant treatment benefit across multiple efficacy measures at Week 96 versus teriflunomide in participants who had not received prior DMT.
Feb, 28, 2023
Their advanced algorithms and expert analysis provide real-time alerts on stocks to help you make profitable trades.
Nov, 30, 2022
Full Technical Analysis at https://youtu.be/2qmFW567-gQ Appreciate You Subscribing and Please Donāt Hesitate to Ask Anything!!